COMMUNIQUÉS West-GlobeNewswire

Menlo Therapeutics Reports First Quarter 2018 Financial Results

09/05/2018 - 22:05

REDWOOD CITY, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus associated [...]

resTORbio to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

09/05/2018 - 22:05

BOSTON, May 09, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]

Dova Pharmaceuticals Reports First Quarter 2018 Operating and Financial Results

09/05/2018 - 22:05

PDUFA date for avatrombopag of May 21, 2018 Conference call scheduled for 4:30 p.m. ET today DURHAM, N.C., May 09, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ), a pharmaceutical company focused on [...]

miRagen Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update

09/05/2018 - 22:05

MRG-110 advanced into clinical development with the initiation of two Phase 1 clinical trials in collaboration with Servier Preclinical data released in two separate ophthalmology programs targeting microRNA-29 and the [...]

TRACON Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update

09/05/2018 - 22:05

SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

CytomX Therapeutics Announces First Quarter 2018 Financial Results

09/05/2018 - 22:05

- Initial clinical data from the Phase 1/2 CX-072 program to be reported at American Society of Clinical Oncology Annual Meeting - SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc [...]

ICU Medical, Inc. Announces First Quarter 2018 Results

09/05/2018 - 22:05

SAN CLEMENTE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]

XOMA Reports First Quarter 2018 Financial Results

09/05/2018 - 22:05

Current cash balance sufficient to fund operations for multiple years EMERYVILLE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA ), a pioneer in the discovery, development and licensing of [...]

MRI Interventions, Inc. to Announce First Quarter 2018 Results on May 15

09/05/2018 - 22:05

IRVINE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) announced that it will release financial results for its 2018 first quarter, which ended March 31, 2018, on Tuesday, May 15, 2018 [...]

Inovio Pharmaceuticals Reports 2018 First Quarter Financial Results

09/05/2018 - 22:05

PLYMOUTH MEETING, Pa., May 09, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ), a late-stage biotechnology company focused on the discovery, development, and commercialization of DNA immunotherapies [...]

Wright Medical Group N.V. Reports 2018 First Quarter Financial Results

09/05/2018 - 22:05

First Quarter 2018 Net Sales of $199 Million First Quarter 2018 Net Loss From Continuing Operations of $20 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $27 Million U.S. Upper Extremities Business [...]

Adamas Announces New Employment Inducement Grant

09/05/2018 - 22:05

EMERYVILLE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the compensation committee of the company’s board of directors granted four new employees the option [...]

Fluidigm to Participate in Upcoming Investor Events

09/05/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ), an innovative life science company that develops, manufactures and markets multiparameter mass cytometry technology and [...]

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018

09/05/2018 - 22:05

Reports Net Revenues of $58.4 Million for the Three Months Ended March 31, 2018 RANCHO CUCAMONGA, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) (“Amphastar” or the “Company”) [...]

Novavax Reports First Quarter 2018 Financial Results

09/05/2018 - 22:05

GAITHERSBURG, Md., May 09, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX ) today announced its financial results for the first quarter ended March 31, 2018. First Quarter and Subsequent Achievements: RSV F [...]

ChemoCentryx Reports First Quarter 2018 Financial Results and Recent Highlights

09/05/2018 - 22:05

-- Patient enrollment in Phase III ADVOCATE trial of avacopan in the treatment of ANCA-associated vasculitis exceeds 85%; Conditional Marketing Authorization (CMA) application under review with European Medicines Agency [...]

Portola Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update

09/05/2018 - 22:05

-- Conference Call Today at 4:30 p.m. ET -- SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today reported financial results for the three months ended March [...]

Aileron Therapeutics Reports First Quarter 2018 Financial Results

09/05/2018 - 22:03

CAMBRIDGE, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN ), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today reported business [...]

Accelerate Diagnostics reports Q1 2018 financial results

09/05/2018 - 22:03

TUCSON, Ariz., May 09, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending March 31, 2018. The company generated revenue of $801,000, up 51% from the prior year [...]